[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_12700 

# __Clinical trial methodologies__

## Risks linked to this technology

* [Mixing measles, mumps, and rubella mmr vaccine to test for broad-spectrum viral immunity](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10783.md)
* [Use of drugs with potential side effects for covid-19 treatment](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10784.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Vaccination development and distribution](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_66.md)

## This technology is mentioned by

* [Wu_current_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_509.md)

